JOHN LAURIELLO: Open Payments
NPI 1639185291 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,160 in 10 payments from 3 companies in 2025. Trend: 2023 $11,685 · 2024 $23,767 · 2025 $15,160
Consulting: $13,775Travel & lodging: $860Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $8,960 |
| E.R. Squibb & Sons, L.L.C. | 3 | $3,500 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $2,700 |
Products named: LYBALVI, ARISTADA.
Industry payments across PA — which companies pay providers there.
